Indivior Pharmaceuticals (INDV) Stock Price, Quote, News & History

Comments

Indivior Pharmaceuticals Inc (INDV) Stock Price, Quote, News & History

INDVNASDAQ

Trade with Public

$32.05

-0.11-0.34%

At close: Mar 5, 4:00 PM EST

$32.12

0.070.22%

After Hours: 4:38 PM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$31.57

$32.05

Volume / Avg.

2.62M / 2.41M

Day Range

$30.87 - $32.15

52 Wk Range

8.64 - 38.00

Market Cap

$4.02B

P/E Ratio

32.70

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.93%

Days to Cover

8.35

Recent Indivior Pharmaceuticals, Inc News

'Follow The Money,' Not The Tariff Noise, Says Expert, Spotlights This New S&P Data Center Cooling Stock Among Top Picks

Kevin Mahn highlighted the potential impact of the recent tariff noise on the market and advised investors to look beyond the headlines.

Namrata Sen

Elastic, Veeva Systems, HIVE Digital And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor

This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

177.00M

Investing Cash Flow (TTM)

-34.00M

Financing Cash Flow (TTM)

15.00M

Free Cash Flow (TTM)

117.00M

Capital Expenditure (TTM)

-60.00M

Net Change in Cash (TTM)

157.00M

Analyst Trends and Forecast

Oct 25

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.00B

PE Ratio (TTM)

32.70

PE Ratio (FWD)

10.82

PEG Ratio (TTM)

PS Ratio (TTM)

3.47

PB Ratio (TTM)

Earnings Yield % (TTM)

3.06%

Earnings Yield % (FWD)

9.24%

EV / EBITDA (TTM)

14.67

Price / EBITDA (TTM)

15.33

Price / Free Cash Flow (TTM)

34.99

Book Value / Share

-$1.66

Company Debt

Total Debt

$322.00M

LT Debt

$304.00M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$250.00M

Total Cash

$445.00M

Debt to Equity

Issuance of Debt (TTM)

$82.00M

Repayment of Debt (TTM)

-$250.00M

Key Statistics

Open

$31.57

$32.05

Volume / Avg.

2.62M / 2.41M

Day Range

$30.87 - $32.15

52 Wk Range

8.64 - 38.00

Market Cap

$4.02B

P/E Ratio

32.70

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.93%

Days to Cover

8.35

About

Sector

Health Care

Industry

Pharmaceuticals

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease.

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Indivior Pharmaceuticals (INDV) stock?

You can purchase shares of Indivior Pharmaceuticals (NASDAQ:INDV) through any online brokerage.

View our list of the best stock brokerages

Who are Indivior Pharmaceuticals (INDV) competitors?

Other companies in Indivior Pharmaceuticals’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), WAVE Life Sciences Ltd (NASDAQ:WVE), Phibro Animal Health Corp (NASDAQ:PAHC), Tarsus Pharmaceuticals Inc (NASDAQ:TARS) and Terns Pharmaceuticals Inc (NASDAQ:TERN).

What is the forecast, or price target, for Indivior Pharmaceuticals (INDV) stock?

Indivior Pharmaceuticals has a consensus price target of $35.75.

What is the current price for Indivior Pharmaceuticals (INDV)?

The stock price for Indivior Pharmaceuticals (NASDAQ: INDV) is $32.12 last updated March 5, 2026 at 4:38 PM EST.

Does Indivior Pharmaceuticals (INDV) pay a dividend?

There are no upcoming dividends for Indivior Pharmaceuticals.

When is Indivior Pharmaceuticals (NASDAQ:INDV) reporting earnings?

Indivior Pharmaceuticals does not have any upcoming earnings scheduled.

Is Indivior Pharmaceuticals (INDV) going to split?

There is no upcoming split for Indivior Pharmaceuticals.

What sector and industry does Indivior Pharmaceuticals (INDV) operate in?

Indivior Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Supernus Pharmaceuticals Inc

NASDAQ:SUPN

$54.27

WAVE Life Sciences Ltd

NASDAQ:WVE

$13.75

4.20%

Phibro Animal Health Corp

NASDAQ:PAHC

$49.59

Tarsus Pharmaceuticals Inc

NASDAQ:TARS

$74.90

Terns Pharmaceuticals Inc

NASDAQ:TERN

$42.00

Axsome Therapeutics Inc

Ocular Therapeutix Inc

NASDAQ:OCUL

$10.31

-0.19%

Key Statistics

Open

$31.57

$32.05

Volume / Avg.

2.62M / 2.41M

Day Range

$30.87 - $32.15

52 Wk Range

8.64 - 38.00

Market Cap

$4.02B

P/E Ratio

32.70

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.93%

Days to Cover

8.35

Recent Indivior Pharmaceuticals, Inc News

'Follow The Money,' Not The Tariff Noise, Says Expert, Spotlights This New S&P Data Center Cooling Stock Among Top Picks

Kevin Mahn highlighted the potential impact of the recent tariff noise on the market and advised investors to look beyond the headlines.

Namrata Sen

Elastic, Veeva Systems, HIVE Digital And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Avi Kapoor

This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

177.00M

Investing Cash Flow (TTM)

-34.00M

Financing Cash Flow (TTM)

15.00M

Free Cash Flow (TTM)

117.00M

Capital Expenditure (TTM)

-60.00M

Net Change in Cash (TTM)

157.00M

Analyst Trends and Forecast

Oct 25

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$4.00B

PE Ratio (TTM)

32.70

PE Ratio (FWD)

10.82

PEG Ratio (TTM)

PS Ratio (TTM)

3.47

PB Ratio (TTM)

Earnings Yield % (TTM)

3.06%

Earnings Yield % (FWD)

9.24%

EV / EBITDA (TTM)

14.67

Price / EBITDA (TTM)

15.33

Price / Free Cash Flow (TTM)

34.99

Book Value / Share

-$1.66

Company Debt

Total Debt

$322.00M

LT Debt

$304.00M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$250.00M

Total Cash

$445.00M

Debt to Equity

Issuance of Debt (TTM)

$82.00M

Repayment of Debt (TTM)

-$250.00M

Key Statistics

Open

$31.57

$32.05

Volume / Avg.

2.62M / 2.41M

Day Range

$30.87 - $32.15

52 Wk Range

8.64 - 38.00

Market Cap

$4.02B

P/E Ratio

32.70

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.93%

Days to Cover

8.35

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry